Home › Hepatitis B › Maryland › Baltimore
Hepatitis B clinical trials in Baltimore, MD
5 studies for Hepatitis B are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
RecruitingPhase 1
- Grifols Investigative site, Baltimore
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RecruitingPhase 2
- University of Maryland, Baltimore
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
RecruitingPhase 1
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
RecruitingPhase 2
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
RecruitingPhase 4
- Mercy Medical Center, Baltimore
About Hepatitis B
Hepatitis B virus is a contagious liver infection spread from person-to-person via blood or body fluids. Who is at risk for HBV? Read about it here.
More about Hepatitis B on MedlinePlus
Hepatitis B trials in other cities
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.